Primary Site >> Stomach Cancer

Gene >> CCL5

  • 2003
  • 2004
  • 2005
  • 2008
  • 2010
  • 2011
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor.
PMID: 12509950
 Ref: Infiltration of CD8+ T cells containing RANTES/CCL5+ cytoplasmic granules in actively inflammatory lesions of human chronic gastritis.
PMID: 14704722
 Ref: Metastases-related genes in the classification of liver and peritoneal metastasis in human gastric cancer.
PMID: 16054651
Ref: The interplay between gastric cancer cell lines and PBMCs mediated by the CC chemokine RANTES plays an important role in tumor progression.
PMID: 16270531
 Ref: Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination.
PMID: 18246596
Ref: Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer.
PMID: 18297689
Ref: RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women.
PMID: 18306985
 Ref: [Chemokine and chemokine receptor related to cancer metastasis].
PMID: 21084802
 Ref: A functional and transcriptomic analysis of NET1 bioactivity in gastric cancer.
PMID: 21284875
Ref: Role of RANTES and its receptor in gastric cancer metastasis.
PMID: 21671175
 Ref: Caveolin-1 protects B6129 mice against Helicobacter pylori gastritis.
PMID: 23592983
Ref: CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination.
PMID: 24466382
 Ref: Differential association of RANTES-403 and IL-1B-1464 polymorphisms on histological subtypes in male Korean patients with gastric cancer.
PMID: 24323564
Ref: 17beta-estradiol inhibits mesenchymal stem cells-induced human AGS gastric cancer cell mobility via suppression of CCL5- Src/Cas/Paxillin signaling pathway.
PMID: 24396281
Ref: Serum chemokine ligand 5 (CCL5/RANTES) level might be utilized as a predictive marker of tumor behavior and disease prognosis in patients with gastric adenocarcinoma.
PMID: 25301002
Ref: The saponin DT-13 inhibits gastric cancer cell migration through down-regulation of CCR5-CCL5 axis.
PMID: 25480514
 Ref: Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells.
PMID: 25483835
 Ref: CCL5 secreted by tumor associated macrophages may be a new target in treatment of gastric cancer.
PMID: 26796278
Ref: C-C motif chemokine ligand 5 (CCL5) levels in gastric cancer patient sera predict occult peritoneal metastasis and a poorer prognosis.
PMID: 27398691
Ref: Elevated level of some chemokines in plasma of gastric cancer patients.
PMID: 28450798
 Ref: Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells.
PMID: 28835422
Ref: Down-regulation of KLF5 in cancer-associated fibroblasts inhibit gastric cancer cells progression by CCL5/CCR5 axis.
PMID: 28934010
 Ref: Genomic predictors of chemotherapy efficacy in advanced or recurrent gastric cancer in the GC0301/TOP002 phase III clinical trial.
PMID: 29061504
Ref: A novel pretherapeutic gene expression-based risk score for treatment guidance in gastric cancer.
PMID: 29069277
Ref: Blockade of CCR5-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy in gastric cancer.
PMID: 29303012
Ref: Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.
PMID: 29772686